Compliance Analysis for Remote Spirometry in Mild to Moderate Asthma

Remote spirometry offers real advantages. Patients test at home, data arrives far more frequently, and results compare well with clinic spirometry. However, one question stops sponsors: will patients actually do it, twice a day, for weeks?

This poster answers it with data. Koneksa and Regeneron analyzed 3,024 expected pulmonary function tests across three asthma studies in the US and UK, tracking whether 54 subjects completed twice-daily home spirometry over 28 days.

View the poster and supplement, or contact us to discuss remote spirometry and respiratory measurement for your program.

Download the Poster

Complete the form to access the full resource.

What You'll Learn

Compliance rates against four escalating criteria, from twice-daily completion through zero missed days
How completion varied by morning versus evening, and weekday versus weekend
Whether compliance declined across the 28-day period, a common concern in remote data capture
The device, training, and time-window protocol behind the results

Related Resources

koneksa_podcast_cover_image
Human-in-the-Loop: Why Experts Matter More in the Age of AIPodcast

Human-in-the-Loop: Why Experts Matter More in the Age of AI

Lodestar Webinar thumnbail
Meet Lodestarâ„¢: Your North Star for Regulatory SubmissionsWebinar

Meet Lodestarâ„¢: Your North Star for Regulatory Submissions

Cardiovascular measurement overview showing Koneksa's framework across cardiac physiology, mobility, imaging, biomarkers, and PROs
Cardiovascular MeasurementFact Sheet

Cardiovascular Measurement